Literature DB >> 2812286

Sex-related differences in the effects of morphine and stress on visceral pain.

A I Baamonde1, A Hidalgo, F Andrés-Trelles.   

Abstract

The effect of morphine (in the absence of stress and after a type of naloxone-sensitive swim-stress) on the painful contractions induced by intraperitoneal injection of hypertonic saline was studied in four groups of rats: normally cycling females in oestrus, males, ovariectomized females and females subjected to constant light, to induce a hyperoestrogenemic state. In the absence of swim-stress, the sensitivity to morphine was maximum for males (i.e. analgesia was produced with the smallest doses). After swim-stress, both males and ovariectomized rats showed less sensitivity to the analgesic effect of morphine than normal females in oestrus, while females subjected to constant light were less sensitive. In females in natural oestrus, but not in the other groups, small doses (0.05 mg/kg) of morphine, paradoxically reduced the analgesic effect of swim-stress considerably. These results show the importance of sex-related factors in the sensitivity of visceral pain to morphine and stress. A selective role for endogenous androgens and oestrogens is likely.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2812286     DOI: 10.1016/0028-3908(89)90197-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  16 in total

1.  PAG mu opioid receptor activation underlies sex differences in morphine antinociception.

Authors:  Scott A Bernal; Michael M Morgan; Rebecca M Craft
Journal:  Behav Brain Res       Date:  2006-11-21       Impact factor: 3.332

Review 2.  Somatic symptom reporting in women and men.

Authors:  A J Barsky; H M Peekna; J F Borus
Journal:  J Gen Intern Med       Date:  2001-04       Impact factor: 5.128

3.  Mu (mu) opioid receptor regulation of ethanol-induced dopamine response in the ventral striatum: evidence of genotype specific sexual dimorphic epistasis.

Authors:  Martin O Job; Amanda Tang; F Scott Hall; Ichiro Sora; George R Uhl; Susan E Bergeson; Rueben A Gonzales
Journal:  Biol Psychiatry       Date:  2007-03-06       Impact factor: 13.382

4.  Sex specificity in methadone analgesia in the rat: a population pharmacokinetic and pharmacodynamic approach.

Authors:  Monica Rodriguez; M Angeles Carlos; Ignacio Ortega; Elena Suarez; Rosario Calvo; John C Lukas
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

5.  mu-opioid receptor-mediated antinociceptive responses differ in men and women.

Authors:  Jon-Kar Zubieta; Yolanda R Smith; Joshua A Bueller; Yanjun Xu; Michael R Kilbourn; Douglas M Jewett; Charles R Meyer; Robert A Koeppe; Christian S Stohler
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

6.  Naltrexone alters alcohol self-administration behaviors and hypothalamic-pituitary-adrenal axis activity in a sex-dependent manner in rats.

Authors:  Steven J Nieto; Cana B Quave; Therese A Kosten
Journal:  Pharmacol Biochem Behav       Date:  2018-02-24       Impact factor: 3.533

Review 7.  Classical conditioning and pain: conditioned analgesia and hyperalgesia.

Authors:  Gonzalo Miguez; Mario A Laborda; Ralph R Miller
Journal:  Acta Psychol (Amst)       Date:  2013-11-22

Review 8.  Neuronal and glial factors contributing to sex differences in opioid modulation of pain.

Authors:  Dayna L Averitt; Lori N Eidson; Hillary H Doyle; Anne Z Murphy
Journal:  Neuropsychopharmacology       Date:  2018-06-23       Impact factor: 7.853

Review 9.  Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak.

Authors:  Grace C Rossi; Richard J Bodnar
Journal:  Cell Mol Neurobiol       Date:  2020-09-24       Impact factor: 5.046

10.  No antinociceptive synergy between morphine and delta-9-tetrahydrocannabinol in male and female rats with persistent inflammatory pain.

Authors:  Stevie C Britch; Rebecca M Craft
Journal:  Behav Pharmacol       Date:  2021-12-01       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.